REV-ERB agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common supplier description |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water |
| Typical storage | −20 °C, desiccated, dark | For research samples |
| Analytical method | LC-MS/MS | Used for detection and quantification |
| Regulatory status | Prohibited in sport | WADA metabolic modulator class |
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
== Affected areas == Many states are directly affected by the drug trade that occurs in the Indian Ocean region, both economically and socially. These detrimental effects are felt throughout many different countries, in a variety of ways, such as a possible increase in drug use by the populations and heightened levels of corruption.
=== Mitosis === Yet another major aspect of cellular behavior that is thought to include rho protein signaling is mitosis. While rho GTPase activity was thought for years to be restricted to actin polymerization and therefore to cytokinesis, which occurs after mitosis, new evidence has arisen that shows some activity in microtubule formation and the process of mitosis itself. This topic is still debated, and there is evidence both for and against for the importance of rho in mitosis.
== Other activities == As an actress, Pansino appeared on Season 2 of VH1's Scream Queens, a reality series in which the prize was a role in one of the Saw films; she finished in 9th place. Following this, Pansino appeared in small roles on shows such as Parks and Recreation and CSI: Crime Scene Investigation. She voiced the role of Violet in the animated web series Broken Quest in 2013. In 2015, she made a cameo in the music video for "Dessert" by Dawin ft. Silentó. In 2016, she had a recurring voice role on the television series Emo Dad and also guest starred in the Disney Channel series Bizaardvark as herself. Pansino starred on the third season of YouTube Red's Escape the Night as The Jetsetter in 2018, the fourth season as The Socialite in 2019, and the later three-episode follow-up series as The Fitness Instructor in 2025. Pansino and the rest of the cast for both the third and fourth seasons were nominated for Streamy Awards. In 2023, she guest starred as a wedding planner on NCIS: Los Angeles, which she described as a "dream come true." Pansino is a classically trained singer. She released her debut single entitled, "Perfect Together", in 2015. Produced by Kurt Hugo Schneider, it was initially released as a single on iTunes, but a music video was released later the same year; as of 2019, it has over 20 million views. She has continued to post covers of popular songs on her YouTube channel, notably of songs like "Part of Your World" from the Disney movie The Little Mermaid.
Sources: en.wikipedia.org
Present data show that (R)-phenylpiracetam increases motivation, i.e., the work load, which animals are willing to perform to obtain more rewarding food. At the same time consumption of freely available normal food does not increase. Generally this indicates that (R)-phenylpiracetam increase motivation [...] The effect of (R)-phenylpiracetam is much stronger than that of methylphenidate and amphetamine.
== Early life == Carrey was born in Newmarket, Ontario, Canada, to Kathleen (née Oram), a homemaker, and Percy Carrey, a musician and accountant. He was raised Catholic and had three older siblings. His mother was of Irish and Scottish descent, and his father was of French-Canadian ancestry; the family's original surname was Carré. At age eight, he began making faces before a mirror and discovered a talent for doing impressions. At age ten, Carrey wrote a letter to Carol Burnett of the Carol Burnett Show pointing out that he was already a master of impressions and should be considered for a role on the show; he was overjoyed when he received a form letter reply. A fan of Monty Python, whose television show Monty Python's Flying Circus aired in the 1970s, in 2014 Carrey appeared on Monty Python's Best Bits (Mostly) and recalled the effect on him of Ernest Scribbler (played by Michael Palin) laughing himself to death in "The Funniest Joke in the World" sketch. Radio Times states, "You'll see why immediately: Palin's performance is uncannily Carreyesque." Carrey spent his early years in the borough of Scarborough, Ontario, part of Metropolitan Toronto, where he attended Blessed Trinity Catholic Elementary School in North York. His family later moved to Burlington, Ontario, where they would spend eight years; Carrey attended Aldershot High School while there. Some time later, his family became homeless and lived together in a Volkswagen van while teenage Carrey and his brother spent months living in a tent in Charles Daley Park on the Lake Ontario shore in Lincoln, Ontario.
=== Myotonic muscular dystrophy === Iplex was investigated in a Phase II clinical study at the University of Rochester School of Medicine, with funding provided by the Muscular Dystrophy Association and the National Institutes of Health. This Phase II program studied the safety and tolerability of once-daily, subcutaneous injection of Iplex in patients with MMD. While patients with MMD showed significant increases in total muscle weight, testosterone levels, and LDL levels, and significant decreases in triglyceride and HDL levels, functional assays such as grip strength and walk tests did not show improvement.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.
Detection commonly uses liquid chromatography–tandem mass spectrometry. This method can identify the compound in urine or blood at low concentrations.
Typical guidance is −20 °C, dry, and protected from light. Solutions should be aliquoted and limited freeze–thaw cycles should be used.
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.